查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1873364

病理检测：全球市场占有率和排名、总收入和需求预测（2025-2031年）

Pathological Examination - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 116 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球病理检测市场预计在 2024 年达到 341.33 亿美元，预计到 2031 年将达到 659.12 亿美元，2025 年至 2031 年的复合年增长率为 10.0%。

病理学是一门医学诊断学科，它透过分析组织、细胞和体液来确定疾病的性质、病因和进展。病理学涵盖组织病理学、细胞学、免疫组织化学和分子病理学等技术。作为诊断包括癌症在内的多种疾病的黄金标准，病理学在临床决策、手术计划制定和预后评估中发挥着至关重要的作用。

病理检测市场的发展主要受全球癌症和其他慢性疾病发生率上升的驱动，这些疾病都需要基于组织的诊断。随着医疗保健系统向精准医疗转型，对组织病理学、细胞学和分子病理学等精准的早期诊断工具的需求持续增长。数位病理学、免疫组织化学 (IHC) 和次世代定序(NGS) 等技术的进步，拓展了病理学的应用范围，使其超越了传统的显微镜检查，从而提高了工作流程效率、诊断准确性，并实现了个性化治疗策略。

儘管病理检测市场具有巨大的成长潜力，但仍面临许多挑战，包括训练有素的病理学家短缺，尤其是在开发中国家。传统病理的手动工作流程耗时且容易出错。此外，采用数位化病理需要大量的基础性投资、标准化以及监管核准。而且，组织样本品质的差异、复杂的报销环境以及与医院资讯系统（HIS/LIS）的整合难题，都持续阻碍先进病理技术的广泛应用。

本报告旨在对全球病理检测市场进行全面分析，重点关注总收入、市场份额和主要企业的排名，并按地区/国家、类型和应用对病理检测进行分析。

本报告以销售收入为指标，对病理检测市场规模、估算和预测进行了呈现，以2024年为基准年，并包含了2020年至2031年的历史数据和预测数据。报告运用定量和定性分析相结合的方法，帮助读者制定业务/成长策略，评估市场竞争格局，分析公司在当前市场中的地位，并就病理检测做出明智的商业决策。

市场区隔

公司

  • Quest Diagnostics
  • Sonic Healthcare
  • Lab Corp
  • Unilabs
  • SYNLAB International
  • BML
  • Pathologists Diagnostic
  • StageBio
  • KingMed Diagnostics Group
  • Dian Diagnostics Group
  • Adicon Clinical Laboratories Inc.
  • Huayin Health

按类型分類的细分市场

  • 组织病理学
  • 细胞病理学
  • 免疫组织化学病理学
  • 分子病理学

应用领域

  • 医院
  • 临床检查室

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Pathological Examination was estimated to be worth US$ 34133 million in 2024 and is forecast to a readjusted size of US$ 65912 million by 2031 with a CAGR of 10.0% during the forecast period 2025-2031.

Pathological examination is a medical diagnostic process that involves the analysis of tissues, cells, or bodily fluids to determine the nature, cause, and extent of disease. It includes techniques such as histopathology, cytology, immunohistochemistry, and molecular pathology. As the gold standard for diagnosing cancers and many other diseases, pathological examination plays a critical role in clinical decision-making, surgical planning, and prognosis assessment.

The pathological examination market is driven by the increasing global incidence of cancer and other chronic diseases that require tissue-based diagnosis. As healthcare systems shift toward precision medicine, the demand for accurate, early-stage diagnostic tools such as histopathology, cytology, and molecular pathology continues to rise. Technological advancements-such as digital pathology, immunohistochemistry (IHC), and next-generation sequencing (NGS)-have expanded the scope of pathology beyond traditional microscopy, improving workflow efficiency, diagnostic accuracy, and enabling personalized treatment strategies.

Despite strong growth potential, the pathological examination market faces key challenges including a shortage of trained pathologists, especially in developing countries. Manual workflow in traditional pathology can be time-consuming and error-prone, and digital pathology implementation requires significant infrastructure investment, standardization, and regulatory approval. Furthermore, variability in tissue sample quality, complex reimbursement environments, and integration issues with hospital information systems (HIS/LIS) continue to pose barriers to the widespread adoption of advanced pathology technologies.

This report aims to provide a comprehensive presentation of the global market for Pathological Examination, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pathological Examination by region & country, by Type, and by Application.

The Pathological Examination market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pathological Examination.

Market Segmentation

By Company

  • Quest Diagnostics
  • Sonic Healthcare
  • Lab Corp
  • Unilabs
  • SYNLAB International
  • BML
  • Pathologists Diagnostic
  • StageBio
  • KingMed Diagnostics Group
  • Dian Diagnostics Group
  • Adicon Clinical Laboratories Inc.
  • Huayin Health

Segment by Type

  • Histopathology
  • Cytopathology
  • Immunohistochemical Pathology
  • Molecular Pathology

Segment by Application

  • Hospital
  • Medical Laboratory

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Pathological Examination company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Pathological Examination in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Pathological Examination in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Pathological Examination Product Introduction
  • 1.2 Global Pathological Examination Market Size Forecast (2020-2031)
  • 1.3 Pathological Examination Market Trends & Drivers
    • 1.3.1 Pathological Examination Industry Trends
    • 1.3.2 Pathological Examination Market Drivers & Opportunity
    • 1.3.3 Pathological Examination Market Challenges
    • 1.3.4 Pathological Examination Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Pathological Examination Players Revenue Ranking (2024)
  • 2.2 Global Pathological Examination Revenue by Company (2020-2025)
  • 2.3 Key Companies Pathological Examination Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Pathological Examination Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Pathological Examination
  • 2.6 Pathological Examination Market Competitive Analysis
    • 2.6.1 Pathological Examination Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Pathological Examination Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pathological Examination as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Histopathology
    • 3.1.2 Cytopathology
    • 3.1.3 Immunohistochemical Pathology
    • 3.1.4 Molecular Pathology
  • 3.2 Global Pathological Examination Sales Value by Type
    • 3.2.1 Global Pathological Examination Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Pathological Examination Sales Value, by Type (2020-2031)
    • 3.2.3 Global Pathological Examination Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Medical Laboratory
  • 4.2 Global Pathological Examination Sales Value by Application
    • 4.2.1 Global Pathological Examination Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Pathological Examination Sales Value, by Application (2020-2031)
    • 4.2.3 Global Pathological Examination Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Pathological Examination Sales Value by Region
    • 5.1.1 Global Pathological Examination Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Pathological Examination Sales Value by Region (2020-2025)
    • 5.1.3 Global Pathological Examination Sales Value by Region (2026-2031)
    • 5.1.4 Global Pathological Examination Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Pathological Examination Sales Value, 2020-2031
    • 5.2.2 North America Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Pathological Examination Sales Value, 2020-2031
    • 5.3.2 Europe Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Pathological Examination Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Pathological Examination Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Pathological Examination Sales Value, 2020-2031
    • 5.5.2 South America Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Pathological Examination Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Pathological Examination Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Pathological Examination Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Pathological Examination Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Pathological Examination Sales Value, 2020-2031
    • 6.3.2 United States Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Pathological Examination Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Pathological Examination Sales Value, 2020-2031
    • 6.4.2 Europe Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Pathological Examination Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Pathological Examination Sales Value, 2020-2031
    • 6.5.2 China Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Pathological Examination Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Pathological Examination Sales Value, 2020-2031
    • 6.6.2 Japan Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Pathological Examination Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Pathological Examination Sales Value, 2020-2031
    • 6.7.2 South Korea Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Pathological Examination Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Pathological Examination Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Pathological Examination Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Pathological Examination Sales Value, 2020-2031
    • 6.9.2 India Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Pathological Examination Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Quest Diagnostics
    • 7.1.1 Quest Diagnostics Profile
    • 7.1.2 Quest Diagnostics Main Business
    • 7.1.3 Quest Diagnostics Pathological Examination Products, Services and Solutions
    • 7.1.4 Quest Diagnostics Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Quest Diagnostics Recent Developments
  • 7.2 Sonic Healthcare
    • 7.2.1 Sonic Healthcare Profile
    • 7.2.2 Sonic Healthcare Main Business
    • 7.2.3 Sonic Healthcare Pathological Examination Products, Services and Solutions
    • 7.2.4 Sonic Healthcare Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Sonic Healthcare Recent Developments
  • 7.3 Lab Corp
    • 7.3.1 Lab Corp Profile
    • 7.3.2 Lab Corp Main Business
    • 7.3.3 Lab Corp Pathological Examination Products, Services and Solutions
    • 7.3.4 Lab Corp Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Lab Corp Recent Developments
  • 7.4 Unilabs
    • 7.4.1 Unilabs Profile
    • 7.4.2 Unilabs Main Business
    • 7.4.3 Unilabs Pathological Examination Products, Services and Solutions
    • 7.4.4 Unilabs Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Unilabs Recent Developments
  • 7.5 SYNLAB International
    • 7.5.1 SYNLAB International Profile
    • 7.5.2 SYNLAB International Main Business
    • 7.5.3 SYNLAB International Pathological Examination Products, Services and Solutions
    • 7.5.4 SYNLAB International Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.5.5 SYNLAB International Recent Developments
  • 7.6 BML
    • 7.6.1 BML Profile
    • 7.6.2 BML Main Business
    • 7.6.3 BML Pathological Examination Products, Services and Solutions
    • 7.6.4 BML Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.6.5 BML Recent Developments
  • 7.7 Pathologists Diagnostic
    • 7.7.1 Pathologists Diagnostic Profile
    • 7.7.2 Pathologists Diagnostic Main Business
    • 7.7.3 Pathologists Diagnostic Pathological Examination Products, Services and Solutions
    • 7.7.4 Pathologists Diagnostic Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Pathologists Diagnostic Recent Developments
  • 7.8 StageBio
    • 7.8.1 StageBio Profile
    • 7.8.2 StageBio Main Business
    • 7.8.3 StageBio Pathological Examination Products, Services and Solutions
    • 7.8.4 StageBio Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.8.5 StageBio Recent Developments
  • 7.9 KingMed Diagnostics Group
    • 7.9.1 KingMed Diagnostics Group Profile
    • 7.9.2 KingMed Diagnostics Group Main Business
    • 7.9.3 KingMed Diagnostics Group Pathological Examination Products, Services and Solutions
    • 7.9.4 KingMed Diagnostics Group Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.9.5 KingMed Diagnostics Group Recent Developments
  • 7.10 Dian Diagnostics Group
    • 7.10.1 Dian Diagnostics Group Profile
    • 7.10.2 Dian Diagnostics Group Main Business
    • 7.10.3 Dian Diagnostics Group Pathological Examination Products, Services and Solutions
    • 7.10.4 Dian Diagnostics Group Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Dian Diagnostics Group Recent Developments
  • 7.11 Adicon Clinical Laboratories Inc.
    • 7.11.1 Adicon Clinical Laboratories Inc. Profile
    • 7.11.2 Adicon Clinical Laboratories Inc. Main Business
    • 7.11.3 Adicon Clinical Laboratories Inc. Pathological Examination Products, Services and Solutions
    • 7.11.4 Adicon Clinical Laboratories Inc. Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Adicon Clinical Laboratories Inc. Recent Developments
  • 7.12 Huayin Health
    • 7.12.1 Huayin Health Profile
    • 7.12.2 Huayin Health Main Business
    • 7.12.3 Huayin Health Pathological Examination Products, Services and Solutions
    • 7.12.4 Huayin Health Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Huayin Health Recent Developments

8 Industry Chain Analysis

  • 8.1 Pathological Examination Industrial Chain
  • 8.2 Pathological Examination Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Pathological Examination Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Pathological Examination Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Pathological Examination Market Trends
  • Table 2. Pathological Examination Market Drivers & Opportunity
  • Table 3. Pathological Examination Market Challenges
  • Table 4. Pathological Examination Market Restraints
  • Table 5. Global Pathological Examination Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Pathological Examination Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Pathological Examination Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Pathological Examination Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Pathological Examination
  • Table 10. Global Pathological Examination Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pathological Examination as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Pathological Examination Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Pathological Examination Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Pathological Examination Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Pathological Examination Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Pathological Examination Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Pathological Examination Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Pathological Examination Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Pathological Examination Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Pathological Examination Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Pathological Examination Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Pathological Examination Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Pathological Examination Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Pathological Examination Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Pathological Examination Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Pathological Examination Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Pathological Examination Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Pathological Examination Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Pathological Examination Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Quest Diagnostics Basic Information List
  • Table 32. Quest Diagnostics Description and Business Overview
  • Table 33. Quest Diagnostics Pathological Examination Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Pathological Examination Business of Quest Diagnostics (2020-2025)
  • Table 35. Quest Diagnostics Recent Developments
  • Table 36. Sonic Healthcare Basic Information List
  • Table 37. Sonic Healthcare Description and Business Overview
  • Table 38. Sonic Healthcare Pathological Examination Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Pathological Examination Business of Sonic Healthcare (2020-2025)
  • Table 40. Sonic Healthcare Recent Developments
  • Table 41. Lab Corp Basic Information List
  • Table 42. Lab Corp Description and Business Overview
  • Table 43. Lab Corp Pathological Examination Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Pathological Examination Business of Lab Corp (2020-2025)
  • Table 45. Lab Corp Recent Developments
  • Table 46. Unilabs Basic Information List
  • Table 47. Unilabs Description and Business Overview
  • Table 48. Unilabs Pathological Examination Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Pathological Examination Business of Unilabs (2020-2025)
  • Table 50. Unilabs Recent Developments
  • Table 51. SYNLAB International Basic Information List
  • Table 52. SYNLAB International Description and Business Overview
  • Table 53. SYNLAB International Pathological Examination Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Pathological Examination Business of SYNLAB International (2020-2025)
  • Table 55. SYNLAB International Recent Developments
  • Table 56. BML Basic Information List
  • Table 57. BML Description and Business Overview
  • Table 58. BML Pathological Examination Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Pathological Examination Business of BML (2020-2025)
  • Table 60. BML Recent Developments
  • Table 61. Pathologists Diagnostic Basic Information List
  • Table 62. Pathologists Diagnostic Description and Business Overview
  • Table 63. Pathologists Diagnostic Pathological Examination Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Pathological Examination Business of Pathologists Diagnostic (2020-2025)
  • Table 65. Pathologists Diagnostic Recent Developments
  • Table 66. StageBio Basic Information List
  • Table 67. StageBio Description and Business Overview
  • Table 68. StageBio Pathological Examination Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Pathological Examination Business of StageBio (2020-2025)
  • Table 70. StageBio Recent Developments
  • Table 71. KingMed Diagnostics Group Basic Information List
  • Table 72. KingMed Diagnostics Group Description and Business Overview
  • Table 73. KingMed Diagnostics Group Pathological Examination Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Pathological Examination Business of KingMed Diagnostics Group (2020-2025)
  • Table 75. KingMed Diagnostics Group Recent Developments
  • Table 76. Dian Diagnostics Group Basic Information List
  • Table 77. Dian Diagnostics Group Description and Business Overview
  • Table 78. Dian Diagnostics Group Pathological Examination Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Pathological Examination Business of Dian Diagnostics Group (2020-2025)
  • Table 80. Dian Diagnostics Group Recent Developments
  • Table 81. Adicon Clinical Laboratories Inc. Basic Information List
  • Table 82. Adicon Clinical Laboratories Inc. Description and Business Overview
  • Table 83. Adicon Clinical Laboratories Inc. Pathological Examination Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Pathological Examination Business of Adicon Clinical Laboratories Inc. (2020-2025)
  • Table 85. Adicon Clinical Laboratories Inc. Recent Developments
  • Table 86. Huayin Health Basic Information List
  • Table 87. Huayin Health Description and Business Overview
  • Table 88. Huayin Health Pathological Examination Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Pathological Examination Business of Huayin Health (2020-2025)
  • Table 90. Huayin Health Recent Developments
  • Table 91. Key Raw Materials Lists
  • Table 92. Raw Materials Key Suppliers Lists
  • Table 93. Pathological Examination Downstream Customers
  • Table 94. Pathological Examination Distributors List
  • Table 95. Research Programs/Design for This Report
  • Table 96. Key Data Information from Secondary Sources
  • Table 97. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Pathological Examination Product Picture
  • Figure 2. Global Pathological Examination Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Pathological Examination Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Pathological Examination Report Years Considered
  • Figure 5. Global Pathological Examination Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pathological Examination Revenue in 2024
  • Figure 7. Pathological Examination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Histopathology Picture
  • Figure 9. Cytopathology Picture
  • Figure 10. Immunohistochemical Pathology Picture
  • Figure 11. Molecular Pathology Picture
  • Figure 12. Global Pathological Examination Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 13. Global Pathological Examination Sales Value Market Share by Type, 2024 & 2031
  • Figure 14. Product Picture of Hospital
  • Figure 15. Product Picture of Medical Laboratory
  • Figure 16. Global Pathological Examination Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 17. Global Pathological Examination Sales Value Market Share by Application, 2024 & 2031
  • Figure 18. North America Pathological Examination Sales Value (2020-2031) & (US$ Million)
  • Figure 19. North America Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • Figure 20. Europe Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 21. Europe Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Asia Pacific Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Asia Pacific Pathological Examination Sales Value by Region (%), 2024 VS 2031
  • Figure 24. South America Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. South America Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • Figure 26. Middle East & Africa Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. Middle East & Africa Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Key Countries/Regions Pathological Examination Sales Value (%), (2020-2031)
  • Figure 29. United States Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. United States Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 31. United States Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 32. Europe Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Europe Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 34. Europe Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 35. China Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. China Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 37. China Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 38. Japan Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. Japan Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 40. Japan Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 41. South Korea Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. South Korea Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 43. South Korea Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 44. Southeast Asia Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. Southeast Asia Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 46. Southeast Asia Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 47. India Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. India Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 49. India Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 50. Pathological Examination Industrial Chain
  • Figure 51. Pathological Examination Manufacturing Cost Structure
  • Figure 52. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 53. Bottom-up and Top-down Approaches for This Report
  • Figure 54. Data Triangulation
  • Figure 55. Key Executives Interviewed